Literature DB >> 8942628

Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus.

J F Doreleijers1, J P Langedijk, K Hård, R Boelens, J A Rullmann, W M Schaaper, J T van Oirschot, R Kaptein.   

Abstract

The three-dimensional solution structure of the immunodominant central conserved region of the attachment protein G (BRSV-G) of bovine respiratory syncytial virus has been determined by nuclear magnetic resonance (NMR) spectroscopy. In the 32-residue peptide studied, 19 residues form a small rigid core composed of two short helices, connected by a type I' turn, and linked by two disulfide bridges. This unique fold is among the smallest stable tertiary structures known and could therefore serve as an ideal building block for the design of de novo proteins and as a test case for modeling studies. A characteristic hydrophobic pocket, lined by conserved residues, lies at the surface of the peptide and may play a role in receptor binding. This work provides a structural basis for further peptide vaccine development against the severe diseases associated with the respiratory syncytial viruses in both cattle and man.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942628     DOI: 10.1021/bi9621627

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  J J Gorman; B L Ferguson; D Speelman; J Mills
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

2.  Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.

Authors:  Stanislav O Fedechkin; Natasha L George; Ana M Nuñez Castrejon; Joshua R Dillen; Lawrence M Kauvar; Rebecca M DuBois
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

3.  Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies.

Authors:  Stanislav O Fedechkin; Natasha L George; Jacob T Wolff; Lawrence M Kauvar; Rebecca M DuBois
Journal:  Sci Immunol       Date:  2018-03-09

4.  Sequence and unique phylogeny of G genes of bovine respiratory syncytial viruses circulating in Japan.

Authors:  Asuka Kumagai; Kyoko Kawauchi; Kiyohiko Andoh; Shinichi Hatama
Journal:  J Vet Diagn Invest       Date:  2020-11-24       Impact factor: 1.279

5.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

6.  Evolution of bovine respiratory syncytial virus.

Authors:  J F Valarcher; F Schelcher; H Bourhy
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.

Authors:  J P Langedijk; R H Meloen; G Taylor; J M Furze; J T van Oirschot
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans.

Authors:  Estela Escribano-Romero; Joanna Rawling; Blanca García-Barreno; José A Melero
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 9.  Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry.

Authors:  Sayantan Bose; Theodore S Jardetzky; Robert A Lamb
Journal:  Virology       Date:  2015-03-12       Impact factor: 3.616

10.  Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies.

Authors:  Harrison G Jones; Tina Ritschel; Gabriel Pascual; Just P J Brakenhoff; Elissa Keogh; Polina Furmanova-Hollenstein; Ellen Lanckacker; Jehangir S Wadia; Morgan S A Gilman; R Anthony Williamson; Dirk Roymans; Angélique B van 't Wout; Johannes P Langedijk; Jason S McLellan
Journal:  PLoS Pathog       Date:  2018-03-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.